Growth Metrics

Celularity (CELU) Asset Writedowns and Impairment (2020 - 2025)

Celularity (CELU) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 1194.04% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $2.9 million, up 532.39%, while the annual FY2025 figure was $2.9 million, 532.39% up from the prior year.
  • Asset Writedowns and Impairment hit $3.0 million in Q4 2025 for Celularity, up from -$98000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $107.2 million in Q2 2023 and bottomed at -$106.6 million in Q4 2023.
  • Average Asset Writedowns and Impairment over 5 years is $355526.3, with a median of $174000.0 recorded in 2021.
  • Year-over-year, Asset Writedowns and Impairment skyrocketed 49000.0% in 2022 and then tumbled 11993.64% in 2023.
  • Celularity's Asset Writedowns and Impairment stood at $185000.0 in 2021, then soared by 384.32% to $896000.0 in 2022, then crashed by 11993.64% to -$106.6 million in 2023, then skyrocketed by 100.22% to $235000.0 in 2024, then skyrocketed by 1194.04% to $3.0 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $3.0 million, -$98000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.